Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
5 hedge funds and large institutions have $4.1M invested in Counterpath Corp in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
10% less capital invested
Capital invested by funds: $4.58M → $4.1M (-$475K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$21.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.19K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $4.02M | – | – | – |
|
|
CA
2
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
| $35K | – | – | – |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $22K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $19K | +$21.9K | +1,337 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2K | +$2.19K | +134 | +1,675% |
|
CPAH Hedge Fund Activity: Q3 2013 in Review
5 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q3 2013, worth a combined $4.1M — down 10% from $4.58M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CPAH positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $21.9K.
- 5 institutional investors held Counterpath Corp (CPAH) as of Q3 2013, up from 4 in Q2 2013.
- Funds reported $4.1M of Counterpath Corp stock for Q3 2013, down 10% quarter-over-quarter.
- 1 fund opened new Counterpath Corp positions in Q3 2013 and 0 closed out, a net change of +1 holder.
- The largest Counterpath Corp buyer in Q3 2013 was Citadel Advisors, an estimated $21.9K added.
Based on aggregated 13F filings for Q3 2013.